KR890012644A - 간 장해 치료제 - Google Patents

간 장해 치료제 Download PDF

Info

Publication number
KR890012644A
KR890012644A KR1019880004617A KR880004617A KR890012644A KR 890012644 A KR890012644 A KR 890012644A KR 1019880004617 A KR1019880004617 A KR 1019880004617A KR 880004617 A KR880004617 A KR 880004617A KR 890012644 A KR890012644 A KR 890012644A
Authority
KR
South Korea
Prior art keywords
agent
treating
preventing liver
alanine
liver disorders
Prior art date
Application number
KR1019880004617A
Other languages
English (en)
Other versions
KR960008651B1 (ko
Inventor
히사노리 마사끼
쿠니오 토리이
토미오 스다
Original Assignee
우따다 가쯔히로
아지노모또 가부시끼가이샤
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=12606501&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=KR890012644(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by 우따다 가쯔히로, 아지노모또 가부시끼가이샤 filed Critical 우따다 가쯔히로
Publication of KR890012644A publication Critical patent/KR890012644A/ko
Priority to KR1019960017315A priority Critical patent/KR960016569B1/ko
Application granted granted Critical
Publication of KR960008651B1 publication Critical patent/KR960008651B1/ko

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/02—Antidotes

Abstract

내용 없음.

Description

간 장해 치료제
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음
제1도 및 제2도는 실시예 1에서의 혈장 에탄올 농도와 각성상태에 관한 시험결과를 나타낸 도면이며,
제3도는 실시예 2에서의 생존율에 관한 실험결과를 나타낸 도면이고,

Claims (9)

  1. 알리닌과 글루타민을 1:0.1 내지 10의 몰비로 함유함을 특징으로 하는 간 장해 치료 및 예방제.
  2. 제1항에 있어서, 알콜성인 간 장해 치료 및 예방제.
  3. 제1항에 있어서, 알리닌의 일부 또는 전부가 L-체인 간 장해 치료 및 예방제.
  4. 제1항에 있어서, 글루타민의 일부 또는 전부가 L-체인 간 장해 치료 및 예방제.
  5. 제1항에 있어서, 알라닌의 적어도 일부가 염형태인 간 장해 치료 및 예방제.
  6. 제1항에 있어서, 알라닌의 적어도 일부가 염 형태인 간 장해 치료 및 예방제.
  7. 제1항에 있어서, 성인 1일당 알라닌과 글루타민을 합하여 총 1내지 20g(유리체로 환산하여)이 경구섭취될 수 있도록 한 간 장해 치료 및 예방제.
  8. 제7항에 있어서, 성인의 체중이 40-내지 70kg인 간 장해 치료 및 예방제.
  9. 알라닌과 글루타민을 1:0.1 내지 10의 몰비로 함유함을 특징으로 하는 식품 조성물.
    ※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.
KR1019880004617A 1988-02-24 1988-04-23 간 장해 치료제 KR960008651B1 (ko)

Priority Applications (1)

Application Number Priority Date Filing Date Title
KR1019960017315A KR960016569B1 (ko) 1988-02-24 1996-05-22 알라닌 및 글루타민 함유 식품 조성물

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP63-413368 1988-02-24
JP41368/1988 1988-02-24
JP63041368A JPH01216924A (ja) 1988-02-24 1988-02-24 肝障害治療剤

Related Child Applications (1)

Application Number Title Priority Date Filing Date
KR1019960017315A Division KR960016569B1 (ko) 1988-02-24 1996-05-22 알라닌 및 글루타민 함유 식품 조성물

Publications (2)

Publication Number Publication Date
KR890012644A true KR890012644A (ko) 1989-09-18
KR960008651B1 KR960008651B1 (ko) 1996-06-28

Family

ID=12606501

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019880004617A KR960008651B1 (ko) 1988-02-24 1988-04-23 간 장해 치료제

Country Status (6)

Country Link
US (1) US4987123A (ko)
EP (1) EP0329879B2 (ko)
JP (1) JPH01216924A (ko)
KR (1) KR960008651B1 (ko)
DE (1) DE3883743T3 (ko)
ES (1) ES2059501T5 (ko)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5189016A (en) * 1990-05-18 1993-02-23 Clintec Nutrition Co. Nutrient compositions containing peptides and method for administering the same
CA2068333A1 (en) * 1990-09-10 1992-03-11 Austin L. Shug Composition and method for protecting the heart during reperfusion
GB9121467D0 (en) * 1991-10-10 1991-11-27 Sandoz Nutrition Ltd Improvements in or relating to organic compounds
JP3168669B2 (ja) * 1992-02-26 2001-05-21 味の素株式会社 肝再生促進剤
WO1994016740A1 (en) * 1993-01-29 1994-08-04 Brigham And Women's Hospital The use of nitric oxide-delivering compounds for the treatment or prevention of alcoholic liver injury
WO1995018608A1 (en) * 1994-01-11 1995-07-13 N.V. Nutricia Method of treating disorders of the animal or human body by administering amino acids
US5561111A (en) * 1994-12-23 1996-10-01 The University Of Virginia Patent Foundation Stable glutamine derivatives for oral and intravenous rehydration and nutrition therapy
WO2000068251A1 (en) 1999-05-07 2000-11-16 The University Of Virginia Patent Foundation Biological production of stable glutamine, poly-glutamine derivatives in transgenic organisms and their use for therapeutic purposes
GB0114419D0 (en) * 2001-06-13 2001-08-08 Mars Uk Ltd Health food
SE0201713D0 (sv) 2001-11-23 2002-06-06 Gramineer Internat Ab New methods and use III
JP4559380B2 (ja) * 2002-03-01 2010-10-06 日清ファルマ株式会社 肝疾患治療剤
TWI351278B (en) * 2002-03-01 2011-11-01 Nisshin Pharma Inc Agent for preventing and treating of liver disease
US20060089412A1 (en) * 2004-10-18 2006-04-27 Ajinomoto Co. Inc. Pharmaceutical composition for the treatment of non-alcoholic fatty liver disease
WO2007059031A2 (en) * 2005-11-10 2007-05-24 Massachusetts Institute Of Technology Methods and compositions for raising levels and release of gamma aminobutyric acid
JP5642922B2 (ja) * 2007-04-24 2014-12-17 サントリーホールディングス株式会社 複数の肝障害マーカーを指標とする肝障害の評価方法
JP2012041324A (ja) * 2010-08-23 2012-03-01 Ajinomoto Co Inc 白金含有薬剤投与による肝機能低下の抑制剤
CN103445175B (zh) * 2013-09-17 2014-10-08 深圳万和制药有限公司 具有解酒保肝作用的组合物
JP2016086715A (ja) * 2014-10-31 2016-05-23 アサヒグループホールディングス株式会社 ニンジン由来成分含有飲食品
MX2017016479A (es) 2015-06-19 2018-08-15 Chigurupati Harsha Composicion de bebidas sinergicas.
US20170362394A1 (en) 2016-06-18 2017-12-21 Harsha Chigurupati Composition to Reduce DNA and Hepatic Damage and to Enhance Repair Thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR762M (ko) * 1960-08-31 1961-08-28
FR2372626A1 (fr) * 1976-12-02 1978-06-30 Sertog Compositions therapeutiques a base d'un extrait de plantes et d'amino-acides
JPS6150917A (ja) * 1984-08-20 1986-03-13 Ajinomoto Co Inc 抗アルコ−ル性肝障害組成物
US4870056A (en) * 1986-01-23 1989-09-26 Regents Of The University Of Minnesota Acylated cyanamide composition
JPH0420409A (ja) * 1990-05-14 1992-01-24 Daifuku Co Ltd ストレージ可能なコンベヤ装置

Also Published As

Publication number Publication date
ES2059501T3 (es) 1994-11-16
EP0329879B2 (en) 1997-04-16
JPH01216924A (ja) 1989-08-30
ES2059501T5 (es) 1997-06-16
US4987123A (en) 1991-01-22
DE3883743D1 (de) 1993-10-07
EP0329879A1 (en) 1989-08-30
DE3883743T3 (de) 1997-12-04
KR960008651B1 (ko) 1996-06-28
DE3883743T2 (de) 1994-03-17
EP0329879B1 (en) 1993-09-01

Similar Documents

Publication Publication Date Title
KR890012644A (ko) 간 장해 치료제
KR920019347A (ko) 당뇨병의 치료방법
KR940005285A (ko) 염증성 장 질환, 염증성 피부 질환 및 자반증의 예방 및 치료용 약제제조를 위한 상보적 억제제의 용도
NZ504258A (en) Exendin 3 and 4 agonist compounds for the treatment of diabetes
KR910004187A (ko) 세트랄린을 사용한 조기사정의 치료방법
KR950701820A (ko) 패혈증 및 패혈증-연관 옹고장애의 예방 및 치료(prophylaxs and treatment of sepsis and sepsis-associated coagulation disorders)
KR890016922A (ko) 복합 감미료
WO1996022305A3 (en) Modified peptides
KR910016338A (ko) 클로스트리듐 디피실레 하리증 및 위막성 대장염의 예방 및 치료용 의약조성물
ATE133680T1 (de) Oligosaccharidderivate und deren verwendung in heilmitteln
KR880005144A (ko) 올리고당의 제조법
KR970703763A (ko) 간 재생용 치료제(therapeutic agent for liver regeneration)
KR930700088A (ko) 흡입투여를 위한 타우린-기저 약학 조성물
NZ226427A (en) Synergistic antiviral composition
DK178188A (da) Antivirusmiddel
KR910000130A (ko) 진경제
PT75915B (en) Synergistic antihypertensive compositions
JPS55113721A (en) Immunity regulator
KR910016327A (ko) 호중구에 의한 엘라스타제 방출 저해제로서의 테니댑의 용도
BR0011049A (pt) Fenilciclohexanocarboxamidas substituìdas e seu uso como inibidores de absorção de adenosina
ES455721A1 (es) Procedimiento para la preparacion de una nueva sal de pipe- raziniluracilo.
KR880009656A (ko) 국소 치근막 질환의 치료 또는 예방법
KR900017587A (ko) 바이러스 감염증 치료제의 제조를 위한 티아졸 유도체 티프로티모드의 용도
KR910700263A (ko) 시클로리노펩티드를 포함하는 의약
KR870009723A (ko) 돼지 이질의 치료 및 예방에서 하이그로마이신의 사용

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
G160 Decision to publish patent application
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
FPAY Annual fee payment

Payment date: 20100625

Year of fee payment: 15

EXPY Expiration of term